226 related articles for article (PubMed ID: 7681917)
1. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1993 Apr; 7(4):489-98. PubMed ID: 7681917
[TBL] [Abstract][Full Text] [Related]
2. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
4. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
Lauria F; Raspadori D; Ventura MA; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta MR; Tura S
Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902
[TBL] [Abstract][Full Text] [Related]
5. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
6. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia.
Vidriales MB; Orfao A; González M; Hernández JM; López-Berges MC; García MA; Cañizo MC; Caballero MD; Macedo A; Landolfi C
Leukemia; 1993 Dec; 7(12):2026-9. PubMed ID: 7504772
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
8. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of childhood acute myeloid leukemias expressing lymphoid-associated antigens.
Kawai S; Zha Z; Yamamoto Y; Shimizu H; Fujimoto T
Pediatr Hematol Oncol; 1995; 12(5):463-9. PubMed ID: 8519631
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid-associated antigen expression by acute myeloid leukemia.
Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):185-91. PubMed ID: 8712171
[TBL] [Abstract][Full Text] [Related]
12. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
13. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
[TBL] [Abstract][Full Text] [Related]
14. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
15. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
17. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
Drexler HG; Sperling C; Ludwig WD
Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
19. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
20. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]